| Year |
Citation |
Score |
| 2020 |
Durand-Reville TF, Comita-Prevoir J, Zhang J, Wu X, May-Dracka T, Romero J, Wu F, Chen A, Shapiro AB, Carter N, McLeod S, Giacobbe R, Verheijen J, Lahiri S, Sacco M, et al. Discovery of an Orally Available Diazabicyclooctane Inhibitor (ETX0282) of Class A, C and D Serine β-lactamases. Journal of Medicinal Chemistry. PMID 32658473 DOI: 10.1021/Acs.Jmedchem.0C00579 |
0.337 |
|
| 2020 |
Miller AA, Shapiro AB, McLeod S, Carter NM, Moussa SH, Tommasi R, Mueller JP. In vitro Characterization of ETX1317, a broad-spectrum β-lactamase inhibitor that restores and enhances β-lactam activity against multidrug resistant Enterobacteriales, including carbapenem-resistant strains. Acs Infectious Diseases. PMID 32255609 DOI: 10.1021/Acsinfecdis.0C00020 |
0.358 |
|
| 2020 |
McLeod SM, Moussa SH, Hackel MA, Miller AA. activity of sulbactam-durlobactam against complex isolates collected globally from 2016-2017. Antimicrobial Agents and Chemotherapy. PMID 31988095 DOI: 10.1128/Aac.02534-19 |
0.381 |
|
| 2019 |
Miller A, McLeod S, Mathur T, Morrissey I. 694. In vitro Antibacterial Activity of Sulbactam–Durlobactam (ETX2514SUL) Against 121 Recent Acinetobacter baumannii Isolated from Patients in India Open Forum Infectious Diseases. 6: S314-S314. DOI: 10.1093/Ofid/Ofz360.762 |
0.357 |
|
| 2017 |
McLeod SM, Shapiro AB, Moussa SH, Johnstone M, McLaughlin RE, de Jonge BLM, Miller AA. The frequency and mechanism of spontaneous resistance to sulbactam combined with the novel β-lactamase inhibitor ETX2514 in clinical isolates of Acinetobacter baumannii. Antimicrobial Agents and Chemotherapy. PMID 29133555 DOI: 10.1128/Aac.01576-17 |
0.367 |
|
| 2017 |
Durand-Réville TF, Guler S, Comita-Prevoir J, Chen B, Bifulco N, Huynh H, Lahiri S, Shapiro AB, McLeod SM, Carter NM, Moussa SH, Velez-Vega C, Olivier NB, McLaughlin R, Gao N, et al. ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii. Nature Microbiology. 2: 17104. PMID 28665414 DOI: 10.1038/Nmicrobiol.2017.104 |
0.376 |
|
| 2017 |
McLeod SM, Patey SA, Huband MD, Nichols WW. Impact of defined cell envelope mutations in Escherichia coli on the in vitro antibacterial activity of avibactam/β-lactam combinations. International Journal of Antimicrobial Agents. PMID 28242258 DOI: 10.1016/J.Ijantimicag.2016.12.011 |
0.396 |
|
| 2016 |
McLeod S, Shapiro A, Moussa S, Carter N, Johnstone M, McLaughlin R, Dejonge B, Tommasi R, Mueller J, Miller A. Sulbactam Combined With the Novel β-lactamase Inhibitor ETX2514 for the Treatment of Multidrug-Resistant Acinetobacter baumannii Infections Open Forum Infectious Diseases. 3. DOI: 10.1093/Ofid/Ofw172.1794 |
0.315 |
|
| 2015 |
Nayar AS, Dougherty TJ, Ferguson KE, Granger BA, McWilliams L, Stacey C, Leach LJ, Narita S, Tokuda H, Miller AA, Brown DG, McLeod SM. Novel antibacterial targets and compounds revealed by a high-throughput cell wall reporter assay. Journal of Bacteriology. 197: 1726-34. PMID 25733621 DOI: 10.1128/Jb.02552-14 |
0.338 |
|
| 2015 |
McLeod SM, Fleming PR, MacCormack K, McLaughlin RE, Whiteaker JD, Narita S, Mori M, Tokuda H, Miller AA. Small-molecule inhibitors of gram-negative lipoprotein trafficking discovered by phenotypic screening. Journal of Bacteriology. 197: 1075-82. PMID 25583975 DOI: 10.1128/Jb.02352-14 |
0.318 |
|
| 2014 |
Gao N, McLeod SM, Hajec L, Olivier NB, Lahiri SD, Bryan Prince D, Thresher J, Ross PL, Whiteaker JD, Doig P, Li AH, Hill PJ, Cornebise M, Reck F, Hale MR. Overexpression of Pseudomonas aeruginosa LpxC with its inhibitors in an acrB-deficient Escherichia coli strain. Protein Expression and Purification. 104: 57-64. PMID 25240855 DOI: 10.1016/J.Pep.2014.09.006 |
0.338 |
|
| 2014 |
Abibi A, Ferguson AD, Fleming PR, Gao N, Hajec LI, Hu J, Laganas VA, McKinney DC, McLeod SM, Prince DB, Shapiro AB, Buurman ET. The role of a novel auxiliary pocket in bacterial phenylalanyl-tRNA synthetase druggability. The Journal of Biological Chemistry. 289: 21651-62. PMID 24936059 DOI: 10.1074/Jbc.M114.574061 |
0.406 |
|
| 2014 |
Liu M, Blinn C, McLeod SM, Wiseman JW, Newman JV, Fisher SL, Walkup GK. Secreted Gaussia princeps luciferase as a reporter of Escherichia coli replication in a mouse tissue cage model of infection. Plos One. 9: e90382. PMID 24595353 DOI: 10.1371/Journal.Pone.0090382 |
0.3 |
|
| 2014 |
Ma J, McLeod S, MacCormack K, Sriram S, Gao N, Breeze AL, Hu J. Real-time monitoring of New Delhi metallo-β-lactamase activity in living bacterial cells by 1H NMR spectroscopy. Angewandte Chemie (International Ed. in English). 53: 2130-3. PMID 24458501 DOI: 10.1002/Anie.201308636 |
0.354 |
|
| 2014 |
Gao N, McLeod SM, Hajec H, Lahiri SD, Prince DB, Thresher J, Whiteaker J, Ross P, Olivier NB, Doig P. Overexpression of Pseudomonas aeruginosa LpxC in the Presence of an Inhibitor in an acrB Deletion Escherichia coli strain for Structural Studies Protein Expression and Purification. DOI: 10.2210/Pdb4Okg/Pdb |
0.301 |
|
| 2007 |
Yamaichi Y, Fogel MA, McLeod SM, Hui MP, Waldor MK. Distinct centromere-like parS sites on the two chromosomes of Vibrio spp. Journal of Bacteriology. 189: 5314-24. PMID 17496089 DOI: 10.1128/Jb.00416-07 |
0.328 |
|
| 2006 |
Skoko D, Yoo D, Bai H, Schnurr B, Yan J, McLeod SM, Marko JF, Johnson RC. Mechanism of chromosome compaction and looping by the Escherichia coli nucleoid protein Fis. Journal of Molecular Biology. 364: 777-98. PMID 17045294 DOI: 10.1016/J.Jmb.2006.09.043 |
0.464 |
|
| 2004 |
McLeod SM, Waldor MK. Characterization of XerC- and XerD-dependent CTX phage integration in Vibrio cholerae. Molecular Microbiology. 54: 935-47. PMID 15522078 DOI: 10.1111/J.1365-2958.2004.04309.X |
0.336 |
|
| 2002 |
McLeod SM, Aiyar SE, Gourse RL, Johnson RC. The C-terminal domains of the RNA polymerase alpha subunits: contact site with Fis and localization during co-activation with CRP at the Escherichia coli proP P2 promoter. Journal of Molecular Biology. 316: 517-29. PMID 11866515 DOI: 10.1006/Jmbi.2001.5391 |
0.536 |
|
| 2002 |
Aiyar SE, McLeod SM, Ross W, Hirvonen CA, Thomas MS, Johnson RC, Gourse RL. Architecture of Fis-activated transcription complexes at the Escherichia coli rrnB P1 and rrnE P1 promoters. Journal of Molecular Biology. 316: 501-16. PMID 11866514 DOI: 10.1006/Jmbi.2001.5390 |
0.531 |
|
| 2001 |
McLeod SM, Johnson RC. Control of transcription by nucleoid proteins. Current Opinion in Microbiology. 4: 152-9. PMID 11282470 DOI: 10.1016/S1369-5274(00)00181-8 |
0.478 |
|
| 2000 |
McLeod SM, Xu J, Johnson RC. Coactivation of the RpoS-dependent proP P2 promoter by fis and cyclic AMP receptor protein. Journal of Bacteriology. 182: 4180-7. PMID 10894725 DOI: 10.1128/Jb.182.15.4180-4187.2000 |
0.546 |
|
| 1999 |
McLeod SM, Xu J, Cramton SE, Gaal T, Gourse RL, Johnson RC. Localization of amino acids required for Fis to function as a class II transcriptional activator at the RpoS-dependent proP P2 promoter. Journal of Molecular Biology. 294: 333-46. PMID 10610762 DOI: 10.1006/Jmbi.1999.3262 |
0.539 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2021 |
Durand-Reville TF, Miller AA, O'Donnell JP, Wu X, Sylvester MA, Guler S, Iyer R, Shapiro AB, Carter NM, Velez-Vega C, Moussa SH, McLeod SM, Chen A, Tanudra AM, Zhang J, et al. Rational design of a new antibiotic class for drug-resistant infections. Nature. PMID 34526714 DOI: 10.1038/s41586-021-03899-0 |
0.289 |
|
| 2006 |
McLeod SM, Burrus V, Waldor MK. Requirement for Vibrio cholerae integration host factor in conjugative DNA transfer. Journal of Bacteriology. 188: 5704-11. PMID 16885438 DOI: 10.1128/Jb.00564-06 |
0.286 |
|
| 2016 |
Duvall JR, VerPlank L, Ludeke B, McLeod SM, Lee MD, Vishwanathan K, Mulrooney CA, Le Quement S, Yu Q, Palmer MA, Fleming P, Fearns R, Foley MA, Scherer CA. Novel diversity-oriented synthesis-derived respiratory syncytial virus inhibitors identified via a high throughput replicon-based screen. Antiviral Research. PMID 27059228 DOI: 10.1016/J.Antiviral.2016.03.015 |
0.282 |
|
| 2005 |
McLeod SM, Kimsey HH, Davis BM, Waldor MK. CTXphi and Vibrio cholerae: exploring a newly recognized type of phage-host cell relationship. Molecular Microbiology. 57: 347-56. PMID 15978069 DOI: 10.1111/J.1365-2958.2005.04676.X |
0.28 |
|
| 2021 |
Shapiro AB, Moussa SH, McLeod SM, Durand-Réville T, Miller AA. Durlobactam, a New Diazabicyclooctane β-Lactamase Inhibitor for the Treatment of Infections in Combination With Sulbactam. Frontiers in Microbiology. 12: 709974. PMID 34349751 DOI: 10.3389/fmicb.2021.709974 |
0.279 |
|
| 2023 |
Papp-Wallace KM, McLeod SM, Miller AA. Durlobactam, a Broad-Spectrum Serine β-lactamase Inhibitor, Restores Sulbactam Activity Against Acinetobacter Species. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 76: S194-S201. PMID 37125470 DOI: 10.1093/cid/ciad095 |
0.264 |
|
| 2015 |
Ma J, Cao Q, McLeod SM, Ferguson K, Gao N, Breeze AL, Hu J. Target-based whole-cell screening by ¹H NMR spectroscopy. Angewandte Chemie (International Ed. in English). 54: 4764-7. PMID 25693499 DOI: 10.1002/Anie.201410701 |
0.262 |
|
| 2023 |
Moussa SH, Shapiro AB, McLeod SM, Iyer R, Carter NM, Tsai YK, Siu LK, Miller AA. Molecular drivers of resistance to sulbactam-durlobactam in contemporary clinical isolates of . Antimicrobial Agents and Chemotherapy. e0066523. PMID 37843305 DOI: 10.1128/aac.00665-23 |
0.258 |
|
| 2024 |
McLeod SM, Carter NM, Bradford PA, Miller AA. In vitro antibacterial activity of sulbactam-durlobactam in combination with other antimicrobial agents against Acinetobacter baumannii-calcoaceticus complex. Diagnostic Microbiology and Infectious Disease. 109: 116344. PMID 38735147 DOI: 10.1016/j.diagmicrobio.2024.116344 |
0.229 |
|
| 2024 |
McLeod SM, O'Donnell JP, Narayanan N, Mills JP, Kaye KS. Sulbactam-durlobactam: a β-lactam/β-lactamase inhibitor combination targeting . Future Microbiology. PMID 38426849 DOI: 10.2217/fmb-2023-0248 |
0.225 |
|
| 2023 |
O'Donnell J, Tanudra A, Chen A, Newman J, McLeod SM, Tommasi R. dose response and efficacy of the β-lactamase inhibitor, durlobactam, in combination with sulbactam against the complex. Antimicrobial Agents and Chemotherapy. e0080023. PMID 38092671 DOI: 10.1128/aac.00800-23 |
0.218 |
|
| 2023 |
O'Donnell J, Tanudra A, Chen A, Miller AA, McLeod SM, Tommasi R. pharmacokinetics/pharmacodynamics of the β-lactamase inhibitor, durlobactam, in combination with sulbactam against complex. Antimicrobial Agents and Chemotherapy. e0031223. PMID 38092676 DOI: 10.1128/aac.00312-23 |
0.217 |
|
| 2023 |
McLeod SM, Carter NM, Huband MD, Traczewski MM, Bradford PA, Miller AA. Sulbactam-durlobactam susceptibility test method development and quality control ranges for MIC and disk diffusion tests. Journal of Clinical Microbiology. e0122823. PMID 38095417 DOI: 10.1128/jcm.01228-23 |
0.212 |
|
| 2022 |
Karlowsky JA, Hackel MA, McLeod SM, Miller AA. Activity of Sulbactam-Durlobactam against Global Isolates of - Complex Collected from 2016 to 2021. Antimicrobial Agents and Chemotherapy. e0078122. PMID 36005804 DOI: 10.1128/aac.00781-22 |
0.207 |
|
| 2024 |
Miller AA, Moussa SH, McLeod SM. Characterization of complex isolates and microbiological outcome for patients treated with sulbactam-durlobactam in a phase 3 trial (ATTACK). Antimicrobial Agents and Chemotherapy. e0169823. PMID 38567976 DOI: 10.1128/aac.01698-23 |
0.206 |
|
| 2013 |
Lymburner S, McLeod S, Purtzki M, Roskelley C, Xu Z. Zinc inhibits magnesium-dependent migration of human breast cancer MDA-MB-231 cells on fibronectin. The Journal of Nutritional Biochemistry. 24: 1034-40. PMID 23026493 DOI: 10.1016/j.jnutbio.2012.07.013 |
0.123 |
|
| 2025 |
Luckey A, Altarac D, McLeod SM. Letter to the editor regarding "Alternative drugs for the treatment of gonococcal infections: old and new" . 2024. 22(9):753-759. Expert Review of Anti-Infective Therapy. 1-2. PMID 40323198 DOI: 10.1080/14787210.2025.2502799 |
0.12 |
|
| 2025 |
Paudel S, McLeod S, Gjorcheska S, Barske L. Pax9 drives development of the upper jaw but not teeth in zebrafish. Developmental Biology. 524: 1-16. PMID 40306478 DOI: 10.1016/j.ydbio.2025.04.016 |
0.12 |
|
| 2024 |
McLeod SM, Miller AA, Rana K, Altarac D, Moussa SH, Shapiro AB. Clinical Outcomes for Patients With Monomicrobial vs Polymicrobial Complex Infections Treated With Sulbactam-Durlobactam or Colistin: A Subset Analysis From a Phase 3 Clinical Trial. Open Forum Infectious Diseases. 11: ofae140. PMID 38595956 DOI: 10.1093/ofid/ofae140 |
0.117 |
|
| 2023 |
Kaye KS, McLeod SM, O'Donnell JP, Altarac D. Sulbactam-durlobactam for infections caused by Acinetobacter baumannii-calcoaceticus complex - Authors' reply. The Lancet. Infectious Diseases. PMID 37442148 DOI: 10.1016/S1473-3099(23)00423-1 |
0.091 |
|
| 2013 |
Zimmerman C, Austin P, Khong A, McLeod S, Bean B, Forestieri R, Andersen RJ, Jan E, Roberge M, Roskelley CD. The small molecule genkwanine M induces single mode, mesenchymal tumor cell motility. Experimental Cell Research. 319: 908-17. PMID 23333560 DOI: 10.1016/J.Yexcr.2013.01.005 |
0.086 |
|
| 2025 |
Gjorcheska S, Paudel S, McLeod S, Paulding D, Snape L, Sosa KC, Duan C, Kelsh R, Barske L. Sox10 is required for systemic initiation of bone mineralization. Development (Cambridge, England). PMID 39791977 DOI: 10.1242/dev.204357 |
0.079 |
|
| 2012 |
McLeod SM, Dougherty TJ, Pucci MJ. Novel antibacterial targets/identification of new targets by comparative genomics Antibiotic Discovery and Development. 2147483647: 881-900. DOI: 10.1007/978-1-4614-1400-1_27 |
0.076 |
|
| 1992 |
Britton KT, McLeod S, Koob GF, Hauger R. Pregnane steroid alphaxalone attenuates anxiogenic behavioral effects of corticotropin releasing factor and stress. Pharmacology, Biochemistry, and Behavior. 41: 399-403. PMID 1315440 DOI: 10.1016/0091-3057(92)90117-X |
0.06 |
|
| 1992 |
Klein J, Koren G, McLeod SM. Comparison of methods for prediction of nephrotoxicity during development Developmental Pharmacology and Therapeutics. 19: 80-89. PMID 1340440 DOI: 10.1159/000457468 |
0.059 |
|
| 1993 |
Heilig M, McLeod S, Brot M, Heinrichs SC, Menzaghi F, Koob GF, Britton KT. Anxiolytic-like action of neuropeptide Y: mediation by Y1 receptors in amygdala, and dissociation from food intake effects. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 8: 357-63. PMID 8099792 DOI: 10.1038/Npp.1993.35 |
0.053 |
|
| 1992 |
Heilig M, McLeod S, Koob GK, Britton KT. Anxiolytic-like effect of neuropeptide Y (NPY), but not other peptides in an operant conflict test. Regulatory Peptides. 41: 61-9. PMID 1360689 DOI: 10.1016/0167-0115(92)90514-U |
0.051 |
|
| 2009 |
Thai H, Rangwala S, Gay T, Keating K, McLeod S, Nazarenko I, O'Neil D, Pfister D, Loeffert D. An HPV 16, 18, and 45 genotyping test based on Hybrid Capture® technology Journal of Clinical Virology. 45: S93-S97. PMID 19651375 DOI: 10.1016/S1386-6532(09)70014-9 |
0.043 |
|
| 2015 |
McLeod SM, Hages CJ, Carter NJ, Agrawal R. Synthesis and characterization of 15% efficient CIGSSe solar cells from nanoparticle inks Progress in Photovoltaics: Research and Applications. 23: 1550-1556. DOI: 10.1002/Pip.2588 |
0.042 |
|
| 2022 |
Holland M, Fiorito ME, Gravel ML, McLeod S, Polson J, Incio Serra N, Blain-Moraes S. "We are still doing some magic": exploring the effectiveness of online therapeutic clowning. Arts & Health. 1-16. PMID 35263548 DOI: 10.1080/17533015.2022.2047745 |
0.04 |
|
| 2011 |
Silvera-Batista CA, Scott DC, McLeod SM, Ziegler KJ. A mechanistic study of the selective retention of SDS-suspended single-wall carbon nanotubes on agarose gels Journal of Physical Chemistry C. 115: 9361-9369. DOI: 10.1021/Jp111349X |
0.034 |
|
| 2013 |
Hages CJ, Carter NJ, Moore J, McLeod SM, Miskin CK, Joglekar C, Lundstrom MS, Agrawal R. Device comparison of champion nanocrystal-ink based CZTSSe and CIGSSe solar cells: Capacitance spectroscopy Conference Record of the Ieee Photovoltaic Specialists Conference. 1966-1971. DOI: 10.1109/PVSC.2013.6744856 |
0.033 |
|
| 2010 |
Hovland JA, McLeod SM, Duffrin MW, Johanson G, Berryman DE. School-based screening of the dietary intakes of third graders in rural Appalachian Ohio. The Journal of School Health. 80: 536-43. PMID 21039552 DOI: 10.1111/J.1746-1561.2010.00539.X |
0.033 |
|
| 1967 |
de Jong W, McLeod SM. Effect of autonomic blocking agents on the cardiovascular effects of octapressin in the rat. European Journal of Pharmacology. 1: 93-8. PMID 6060196 |
0.027 |
|
| 2013 |
Carter NJ, Hages CJ, Moore JE, McLeod SM, Miskin CK, Joglekar C, Lundstrom MS, Agrawal R. Analysis of temperature-dependent current-voltage characteristics for CIGSSe and CZTSSe thin film solar cells from nanocrystal inks Conference Record of the Ieee Photovoltaic Specialists Conference. 3062-3065. DOI: 10.1109/PVSC.2013.6745107 |
0.023 |
|
| 2009 |
Huth MM, Daraiseh NM, Henson MA, McLeod SM. Evaluation of the Magic Island: Relaxation for Kids, compact disc. Pediatric Nursing. 35: 290-5. PMID 19916345 |
0.023 |
|
| 1979 |
McLeod SM. Evolution of antihypertensive therapy. Canadian Medical Association Journal. 120: 517-8. PMID 35277 |
0.022 |
|
| 2016 |
Arachchi S, Armstrong DS, Roberts N, Baxter M, McLeod S, Davey MJ, Nixon GM. Clinical outcomes in a high nursing ratio ward setting for children with obstructive sleep apnea at high risk after adenotonsillectomy. International Journal of Pediatric Otorhinolaryngology. 82: 54-7. PMID 26857316 DOI: 10.1016/j.ijporl.2015.12.023 |
0.02 |
|
| 1990 |
McLeod SM, McGlowry SG. Using temperament theory to individualize the psychosocial care of hospitalized children. Children's Health Care : Journal of the Association For the Care of Children's Health. 19: 79-85. PMID 10104959 DOI: 10.1207/s15326888chc1902_2 |
0.018 |
|
| 1990 |
McClowry SG, McLeod SM. The psychosocial responses of school-age children to hospitalization. Children's Health Care : Journal of the Association For the Care of Children's Health. 19: 155-61. PMID 10107919 DOI: 10.1207/s15326888chc1903_4 |
0.016 |
|
| 2003 |
McLeod SM, Kells JA, Putz GJ. Quality characterization of urban runoff to the south Saskatchewan River in the City of Saskatoon Proceedings, Annual Conference - Canadian Society For Civil Engineering. 2003: 2143-2152. |
0.013 |
|
| 2006 |
McLeod SM, Kells JA, Putz GJ. Urban runoff quality characterization and load estimation in Saskatoon, Canada Journal of Environmental Engineering. 132: 1470-1481. DOI: 10.1061/(ASCE)0733-9372(2006)132:11(1470) |
0.01 |
|
| 2014 |
McLeod SM. Patient aggression overstated. The New Zealand Medical Journal. 127: 90. PMID 24997470 |
0.01 |
|
| 2012 |
Cheyne H, Dalgleish L, Tucker J, Kane F, Shetty A, McLeod S, Niven C. Risk assessment and decision making about in-labour transfer from rural maternity care: a social judgment and signal detection analysis. Bmc Medical Informatics and Decision Making. 12: 122. PMID 23114289 DOI: 10.1186/1472-6947-12-122 |
0.01 |
|
| Hide low-probability matches. |